Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 9 studies | 27% ± 12% | |
intestine | 6 studies | 28% ± 10% | |
kidney | 5 studies | 23% ± 10% | |
uterus | 5 studies | 44% ± 12% | |
heart | 4 studies | 22% ± 5% | |
adipose | 4 studies | 33% ± 23% | |
breast | 4 studies | 35% ± 5% | |
esophagus | 3 studies | 30% ± 16% | |
liver | 3 studies | 34% ± 4% | |
prostate | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 76538.20 | 226 / 226 | 99% | 1023.30 | 403 / 406 |
breast | 100% | 80516.74 | 459 / 459 | 96% | 1201.07 | 1076 / 1118 |
lung | 100% | 39662.61 | 576 / 578 | 95% | 676.04 | 1103 / 1155 |
thymus | 100% | 55262.15 | 652 / 653 | 94% | 1028.53 | 571 / 605 |
bladder | 100% | 57065.10 | 21 / 21 | 94% | 798.00 | 474 / 504 |
intestine | 97% | 47091.93 | 941 / 966 | 96% | 565.83 | 505 / 527 |
kidney | 100% | 41953.43 | 89 / 89 | 91% | 1193.13 | 820 / 901 |
uterus | 100% | 84841.04 | 170 / 170 | 89% | 693.70 | 407 / 459 |
prostate | 100% | 50121.18 | 245 / 245 | 85% | 360.86 | 425 / 502 |
esophagus | 96% | 38291.78 | 1380 / 1445 | 86% | 498.73 | 158 / 183 |
ovary | 100% | 122347.53 | 180 / 180 | 67% | 279.26 | 287 / 430 |
skin | 92% | 46542.42 | 1658 / 1809 | 70% | 334.56 | 332 / 472 |
stomach | 67% | 31790.32 | 240 / 359 | 88% | 599.24 | 253 / 286 |
adrenal gland | 96% | 23851.40 | 247 / 258 | 59% | 303.16 | 135 / 230 |
pancreas | 42% | 6745.07 | 138 / 328 | 98% | 1256.17 | 175 / 178 |
adipose | 100% | 75852.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 556.48 | 1 / 1 |
spleen | 99% | 30126.93 | 238 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 43096.03 | 1266 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 29450.50 | 813 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 381.34 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 230.17 | 16 / 29 |
brain | 1% | 135.54 | 23 / 2642 | 22% | 71.36 | 157 / 705 |
muscle | 18% | 3013.92 | 146 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 19.22 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0010906 | Biological process | regulation of glucose metabolic process |
GO_0044342 | Biological process | type B pancreatic cell proliferation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0001558 | Biological process | regulation of cell growth |
GO_0000165 | Biological process | MAPK cascade |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0043567 | Biological process | regulation of insulin-like growth factor receptor signaling pathway |
GO_0043568 | Biological process | positive regulation of insulin-like growth factor receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0031995 | Molecular function | insulin-like growth factor II binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0031994 | Molecular function | insulin-like growth factor I binding |
Gene name | IGFBP4 |
Protein name | Insulin-like growth factor-binding protein 4 (IBP-4) (IGF-binding protein 4) (IGFBP-4) |
Synonyms | IBP4 |
Description | FUNCTION: IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. |
Accessions | ENST00000269593.5 [P22692-1] P22692 |